Scienture Holdings Inc (SCNX) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Scienture Holdings Inc   (NASDAQ: SCNX)

Scienture Holdings Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SCNX Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 97.71 % 70.91 % 67.38 % 46.15 %
Gross Margin (Q2 TTM) 87.72 % 71.7 % 67.8 % 46.36 %
Gross Profit Margin 5 Yr. Avg. 43.11 % 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) 430.94 % 21.48 % 18.44 % 20.46 %
EBITDA Margin (Q2 TTM) -3981.76 % 25.18 % 20.78 % 20.1 %
EBITDA Margin 5 Yr. Avg. --4545.2 % 47.09 % 31.38 % 23.39 %
Operating Margin (Q2 MRQ) -785.63 % 17.3 % 16.52 % 16.05 %
Operating Margin (Q2 TTM) -4878.87 % 20.35 % 17.83 % 16.34 %
Operating Margin 5 Yr. Avg. --4163.61 % 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 13.68 % 10.72 % 13.96 %
Pre-Tax Profit Margin (Q2 TTM) -4520.17 % 16.7 % 12.68 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.98 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) -821.32 % 10.12 % 8.02 % 11.42 %
Net Margin (Q2 TTM) -4620.92 % 13.16 % 9.86 % 10.76 %
Net Margin 5 Yr. Avg. - 5.79 % 6.08 % 10.8 %



Business Segment Profit Margin
 
Losartan Potassium Oral Suspension
  Explore Losartan Potassium Oral Suspension Segment  -